“Biotech is the perfect example that looks a bit frothy, to say the least,” Matthew McGeary, a Stowe, Vt-based fund manager with Eagle Asset Management, which oversees $31.3 billion, said in a phone interview on March 20. “There are clearly investors willing to take on risk and looking for hyper growth. That’s what the industry is getting right now––people flow where the momentum is.”

First « 1 2 3 4 » Next